International law firm Osborne Clarke has advised Mayden, the health tech company behind iaptus, the market-leading Electronic Health Record for psychological therapies in the UK, on its partnership with leading European healthcare investor, G Square, to support the company's next phase of growth.
Over the last 20 years, Mayden has specialised in technology that supports healthcare services, working closely with its customers and industry experts to deliver data driven, outcome focussed and patient centred care.
Mayden’s flagship product - iaptus – is a patient management system used by over 200 mental health services across public, private and voluntary sectors, and it securely holds 8 million patient records and is trusted by over 40,000 users in the UK and internationally. iaptus is customised to meet the clinical demands of healthcare services, providing healthcare professionals with a variety of additional features to maximise the benefits to services, clinicians and patients.
This partnership will see Mayden further cement its commitment to continue to design, build and support insightful and interoperable systems for healthcare services in the UK and abroad.
Mayden recognised that to support their next phase of growth, it required a partner who brings expertise in growing healthcare related companies and shares its views on the challenges and opportunities for healthcare services globally.
Osborne Clarke came highly recommended for company transactions and did not disappoint.
Chris May, founder of Mayden, said: "Osborne Clarke came highly recommended for company transactions and did not disappoint. The team were highly organised, thorough, diligent and hard-working, as well as being an absolute pleasure to work with. I felt throughout that I was in safe and experienced hands. I would have no hesitation in recommending them for anyone aiming to bring investment into their company."
Osborne Clarke's corporate team that advised Mayden was led by partner Chris Yeo, and included senior associates Hannah Stevens and Hannah Maidment and trainee solicitor Elaina Clarke. Additional support was provided by senior associate Ben Doeh (tax) and partner Anika Chandra and associate director Rhiannon Jones (incentives).
Osborne Clarke’s Corporate team is considered a go-to practice for many companies in the life sciences and healthcare sector. The team advises at every stage of company development across all corporate issues, from equity and debt fundraisings to M&A, IPOs and JVs.